Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazia’s Paxalisib and Kintara’s VAL-083 in GBM AGILE Trial

The Global Coalition for Adaptive Research (GCAR) in collaboration with Kazia and Kintara, announced the activation of Kazia’s paxalisib and Kintara’s VAL-083 in Glioblastoma Adaptive Global Innovative Learning Environment (AGILE).